trending Market Intelligence /marketintelligence/en/news-insights/trending/p-wgplsjncfypfbi_7btua2 content esgSubNav
In This List

Concordia International chairman steps down

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Concordia International chairman steps down

Concordia International Corp. said Jordan Kupinsky was stepping down as the company's nonexecutive chairman.

The Canadian pharmaceutical company, which is looking to cut its debt by US$2.4 billion, also appointed Randy Benson to its board.

"We believe that his experience in corporate recapitalizations will benefit our stakeholders as we move forward with our capital structure realignment," Concordia's interim CEO, Graeme Duncan, said of the appointee.